CryoLife, Inc. is a medical devices company. It engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. The company operates in two segments: Medical Devices and Preservation Services. The Medical Devices segment includes external revenues from product sales of BioGlue, BioFoam, PerClot, CardioGenesis cardiac laser therapy, HeRO Graft, and ProCol. The Preservation Services segment offers external services revenues from the preservation of cardiac and vascular tissues. CryoLife was founded by Steven G. Anderson on January 19, 1984 and is headquartered in Kennesaw, GA.